Total Payments
$481.35
2024 Payments
$46.59
Companies
7
Transactions
29
Medicare Patients
781
Medicare Billing
$98,038
Payment Breakdown by Category
Food & Beverage$469.40 (97.5%)
Education$11.95 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $469.40 | 28 | 97.5% |
| Education | $11.95 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $122.78 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $105.29 | 8 | $0 (2019) |
| Melinta Therapeutics, LLC | $85.85 | 5 | $0 (2024) |
| Allergan Inc. | $84.28 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $38.49 | 2 | $0 (2019) |
| ABBVIE INC. | $25.82 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $18.84 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.59 | 2 | ABBVIE INC. ($25.82) |
| 2023 | $18.84 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($18.84) |
| 2021 | $11.95 | 1 | Melinta Therapeutics, LLC ($11.95) |
| 2019 | $105.35 | 6 | Melinta Therapeutics, Inc. ($36.15) |
| 2018 | $144.72 | 9 | Astellas Pharma US Inc ($56.59) |
| 2017 | $153.90 | 10 | Merck Sharp & Dohme Corporation ($67.64) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/17/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: ANTIFUNGALS | ||||||
| 09/08/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.84 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/12/2021 | Melinta Therapeutics, LLC | Vabomere (Drug) | Education | In-kind items and services | $11.95 | General |
| Category: ANTIBIOTICS | ||||||
| 09/25/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/03/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/01/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ANTIBIOTICS | ||||||
| 04/17/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/27/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/23/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ANTIBIOTICS | ||||||
| 10/31/2018 | Melinta Therapeutics, Inc. | Vabomere (Drug), Orbactiv, MINOCIN | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/26/2018 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/30/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/12/2018 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/27/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/28/2018 | Janssen Biotech, Inc. | PREZCOBIX (Drug), Juluca | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/21/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/31/2018 | Astellas Pharma US Inc | CRESEMBA (Drug), MYCAMINE, AMBISOME | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/16/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/25/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID, ZINPLAVA | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/19/2017 | Astellas Pharma US Inc | Cresemba (Drug), Mycamine, Ambisome | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Infectious Diseases | ||||||
| 04/05/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/29/2017 | Astellas Pharma US Inc | Cresemba (Drug), Mycamine, Ambisome | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 185 | 323 | $68,453 | $26,707 |
| 2022 | 5 | 173 | 306 | $59,935 | $20,457 |
| 2021 | 5 | 152 | 264 | $54,885 | $19,026 |
| 2020 | 6 | 271 | 439 | $90,100 | $31,848 |
Total Patients
781
Total Services
1,332
Medicare Billing
$98,038
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 118 | $24,205 | $10,656 | 44.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 54 | $20,752 | $6,839 | 33.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 99 | $15,660 | $5,948 | 38.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 21 | $5,466 | $2,089 | 38.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 31 | $2,370 | $1,175 | 49.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 51 | 121 | $24,200 | $6,619 | 27.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 78 | $17,550 | $6,087 | 34.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 31 | $10,075 | $4,611 | 45.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 32 | 62 | $4,960 | $1,785 | 36.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,150 | $1,353 | 43.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 148 | $29,600 | $8,110 | 27.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 31 | $10,075 | $4,845 | 48.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 35 | $7,875 | $2,822 | 35.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 23 | $5,175 | $2,439 | 47.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 20 | 27 | $2,160 | $809.73 | 37.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 77 | 192 | $38,400 | $10,530 | 27.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 57 | 58 | $18,850 | $8,897 | 47.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 50 | 75 | $16,875 | $5,816 | 34.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 33 | 33 | $7,425 | $3,388 | 45.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 33 | 58 | $4,640 | $1,687 | 36.4% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 21 | 23 | $3,910 | $1,531 | 39.1% |
About Dr. Joel Moses, M.D
Dr. Joel Moses, M.D is a Infectious Disease healthcare provider based in Schenectady, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477661205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Moses, M.D has received a total of $481.35 in payments from pharmaceutical and medical device companies, with $46.59 received in 2024. These payments were reported across 29 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($469.40).
As a Medicare-enrolled provider, Moses has provided services to 781 Medicare beneficiaries, totaling 1,332 services with total Medicare billing of $98,038. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Schenectady, NY
- Active Since 08/29/2006
- Last Updated 02/03/2026
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1477661205
Products in Payments
- CRESEMBA (Drug) $73.28
- AVYCAZ (Drug) $68.06
- Vabomere (Drug) $65.08
- Cresemba (Drug) $49.50
- TEFLARO (Drug) $42.04
- ISENTRESS (Drug) $35.98
- ZERBAXA (Drug) $26.23
- Symtuza (Drug) $22.24
- Rezzayo (Drug) $20.77
- LifeVest (Device) $18.84
- PREZCOBIX (Drug) $16.25
- DIFICID (Drug) $15.13
- NOXAFIL (Drug) $14.63
- CUBICIN RF (Drug) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.